For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Otonomy, Inc.

USPTO Granted Patents = 42

% Expired Patents = 73.8

CIPO Patents = 3

EPO Patents = 3

Trademarks = 2

Forward Citations = 501

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Fabrice Piu (37 out of 43 patents)

Carl Lebel (35 out of 37 patents)

Qiang Ye (34 out of 42 patents)

4. Luis A Dellamary (34 out of 77 patents)

5. Jay Lichter (33 out of 38 patents)

6. Andrew M Trammel (33 out of 35 patents)

7. Jeffrey P Harris (32 out of 35 patents)

8. Benedikt K Vollrath (13 out of 27 patents)

9. Michael Christopher Scaife (12 out of 13 patents)

10. Sergio G Duron (9 out of 17 patents)

11. Scott H Coleman (3 out of 5 patents)

12. Robert Savel (3 out of 5 patents)

13. Sergio G Durón (3 out of 8 patents)

14. Wei-Cheng Liaw (2 out of 4 patents)

15. Jerry Wroblewski (2 out of 3 patents)

Core Competencies:

Auris Formulations

Controlled Release

Otic Disorders

Trk Antagonists

CNS Modulating

Antimicrobial Compositions

Corticosteroids

Otic Diseases

Sensory Cell Modulators

Aural Pressure Modulators

Therapeutic Agents

Colloidal Suspensions

42 patents: Sort by Forward Citations

1. 11123286 - Auris formulations for treating otic diseases and conditions (2021-09-21),

2. 11123285 - Auris formulations for treating OTIC diseases and conditions (2021-09-21),

3. 11040004 - Otic gel formulations for treating otitis externa (2021-06-22),

4. 11034961 - Treatment using truncated Trk B and Trk C antagonists (2021-06-15),

5. 10918594 - Controlled-release CNS modulating compositions and methods for the treatment of otic disorders (2021-02-16),

6. 10821185 - Triglyceride otic formulations and uses thereof (2020-11-03),

7. 10772828 - Controlled release antimicrobial compositions and methods for the treatment of otic disorders (2020-09-15),

8. 10751281 - Auris formulations for treating otic diseases and conditions (2020-08-25),

9. 10272034 - Auris formulations for treating otic diseases and conditions (2019-04-30),

10. 10232044 - Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders (2019-03-19),

11. 10092580 - Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders (2018-10-09),

12. 10066229 - Treatment using truncated Trk B and Trk C antagonists (2018-09-04),

13. 9867778 - Controlled release antimicrobial compositions and methods for the treatment of otic disorders (2018-01-16),

14. 9808460 - Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders (2017-11-07),

15. 9757484 - Sterilization of ciprofloxacin composition (2017-09-12),

Company Overview

Otonomy, Inc. is a biopharmaceutical company based in San Diego, California, focused on developing innovative therapies for otic disorders. The company specializes in advanced drug delivery systems, particularly controlled release formulations that enhance the efficacy of treatments for ear conditions. Otonomy's research encompasses a range of therapeutic areas, including CNS modulating compositions and antimicrobial treatments, with a commitment to improving patient outcomes through targeted therapies and novel corticosteroid applications.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

42 Patents

#147 in San Diego, CA

#1,943 in California

#8,266 in US

#16,374 in the World

San Diego, CA, United States of America

Otonomy, Inc.

Forward Citations = 501

20 inventors:

Fabrice Piu (37 out of 43 patents)

Carl Lebel (35 out of 37 patents)

Qiang Ye (34 out of 42 patents)

4. Luis A Dellamary (34 out of 77 patents)

5. Jay Lichter (33 out of 38 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Otonomy, Inc.. Retrieved from https://idiyas.com/company/otonomy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…